Humanized and Charge‐Optimized CSPG4‐Specific CAR‐T Cells show Enhanced Efficacy against Head and Neck Squamous Cell Carcinoma

Documenti analoghi

• Correction to ‘ MUC1 as a Target for CAR ‐T Therapy in Head and Neck Squamous Cell Carcinoma’
  Pubblicazione: (2024)
• Mohs Micrographic Surgery Efficacy for Solid Organ Transplant Head and Neck Cutaneous Squamous Cell Carcinoma
  di: Kevin L. Li, et al.
  Pubblicazione: (2025)
• Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
  di: Changyu Zhu, et al.
  Pubblicazione: (2025)
• ZNF331 Represses the Proliferation of Head and Neck Squamous Cell Carcinoma via Co‐Repressor TRIM28
  di: Ju Li, et al.
  Pubblicazione: (2024)
• Application and Perspectives of Immunotherapy in Head and Neck Squamous Cell Carcinoma
  di: Zihao Zhang, et al.
  Pubblicazione: (2025)